Richard M. Toselli
Net Worth

Last updated:

What is Richard M. Toselli net worth?

The estimated net worth of Dr. Richard M. Toselli is at least $4,995,780 as of 10 Mar 2020. He owns shares worth $840 as insider and has received compensation worth at least $4,994,940 in InVivo Therapeutics Holdings Corporation.

What is the salary of Richard M. Toselli?

Dr. Richard M. Toselli salary is $832,490 per year as Pres, Chief Executive Officer, Chief Medical Officer & Director in InVivo Therapeutics Holdings Corporation.

How old is Richard M. Toselli?

Dr. Richard M. Toselli is 67 years old, born in 1958.

What stocks does Richard M. Toselli currently own?

As insider, Dr. Richard M. Toselli owns shares in one company:

Company Title Shares Price per share Total value
InVivo Therapeutics Holdings Corporation (NVIV) Pres, Chief Executive Officer, Chief Medical Officer & Director 3,636 $0.23 $840

What does InVivo Therapeutics Holdings Corporation do?

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

Richard M. Toselli insider trading

InVivo Therapeutics Holdings Corporation

Dr. Richard M. Toselli has made only one insider trade between 2019-2020, according to the Form 4 filled with the SEC. He purchased 3,636 units of NVIV stock worth $9,999 on 10 Mar 2020.

As of 10 Mar 2020 he still owns at least 3,636 units of NVIV stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Warrant (right to buy) 3,636 $2.75 $9,999
Purchase
Common Stock 3,636 $2.75 $9,999
Sale
Common Stock 5,229 N/A N/A

InVivo Therapeutics Holdings key executives

InVivo Therapeutics Holdings Corporation executives and other stock owners filed with the SEC: